VIDUS OCULAR
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, the cause of blindness in the United States. The company is based in the United States. As of May 7, 2008, Vidus Ocular, Inc. operates as a subsidiary of Opko Health, Inc.
Similar Organizations
Capillect
Capillect develops a minimally invasive blood collection device to be implemented in the current blood sampling workflows.
Eyoca Medical
Eyoca Medical develops a disposable device for the treatment of chronic total occlusion.
Ocuelar
Ocuelar develops smart cap technology that can measure true medication compliance for glaucoma patients.
Current Employees Featured
More informations about "Vidus Ocular"
Vidus Ocular - Crunchbase Company Profile & Funding
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, …See details»
Vidus Ocular - PitchBook
Provider of medical services in Wilmington, United States. The company offers implantable physiologic device that addresses the shortcomings of glaucoma treatments. Want detailed …See details»
OPKO Health Acquires Company Developing Novel Glaucoma …
Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, is being assessed in a pivotal Phase III trial after …See details»
OPKO Health acquires company developing glaucoma shunt
Jun 5, 2008 · OPKO Health has acquired Vidus Ocular, a privately held company developing a shunt (Aquashunt) to treat glaucoma. The patented device was designed by M. Bruce Shields, …See details»
OPKO Health Acquires Company Developing Novel Glaucoma …
May 8, 2008 · MIAMI, May 7 /PRNewswire-FirstCall/ -- OPKO Health, Inc. (Amex: OPK) today announced that it has acquired Vidus Ocular, Inc., a privately held company that is developing …See details»
Opko acquires Aquashunt maker - Ophthalmology Times
May 16, 2008 · Vidus Ocular, Inc, the developer of the Aquashunt device for glaucoma, has been acquired by OPKO Health, Inc. Aquashunt is an implantable device designed to reduce …See details»
OPKO Health acquires Vidus Ocular - 2008-05-06 - Crunchbase
Acquired Organization: Vidus Ocular Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. ItSee details»
OPKO Health acquires company - Ophthalmology Times
Jul 1, 2008 · Miami-OPKO Health has acquired Vidus Ocular, a privately held company developing a shunt (Aquashunt) to treat glaucoma. The patented device was designed by M. …See details»
Opko Health, Inc. Acquires Company Developing Novel Glaucoma …
May 7, 2008 · Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, is being assessed in a pivotal Phase III …See details»
Vidus Ocular - Crunchbase
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. ItSee details»
Vidus Ocular - VentureRadar
Vidus Ocular was developing the Aquashunt,™ a glaucoma drainage device that can relieve elevated pressure in patients with or at risk for the development of glaucoma. It was …See details»
Vidus Ocular, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Jul 17, 2024 · Explore Vidus Ocular, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Vidus Ocular - Products, Competitors, Financials, Employees ...
About Vidus Ocular. Vidus Ocular develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments.See details»
Suprachoroidal Devices - EyeWiki
The Aquashunt was originally designed by Vidus Ocular, a start up led by Dr. Bruce Shields at Yale University. After initial pre-clinical trials, Vidus was purchased by OPKO Health (Miami, …See details»
Vidus Ocular Inc - Company Profile and News - Bloomberg Markets
Company profile page for Vidus Ocular Inc including stock price, company news, executives, board members, and contact informationSee details»
Vidus Ocular - Contacts, Employees, Board Members ... - Crunchbase
Vidus Ocular has 2 current employee profiles, including Chief Scientific & Medical Officer Bruce Shields. Vidus Ocular, Inc. develops an implantable physiologic device that is designed to …See details»
A New View of the Vitreous in Ocular Health and Disease
Jan 1, 2012 · “The vitreous gel is the orphan organelle of the eye,” said Nancy M. Holekamp, MD, director of retina services at the Pepose Vision Institute and clinical professor of …See details»
Ben R. Bronstein - President and COO @ Vidus Ocular - Crunchbase
Ben R. Bronstein is the President and COO at Vidus Ocular. There is no recent news or activity for this profile. Terms of Service | Privacy Policy | Sitemap | © 2024 Crunchbase Inc. All Rights …See details»
VISION 2020: The Right to Sight - JAMA Network
Improving local eye care services by creating more eye care units,training additional ophthalmologists and other eye care workers, and emphasizingthe adoption of blindness …See details»
Bruce Shields - Chief Scientific & Medical Officer @ Vidus Ocular ...
Bruce Shields is the Chief Scientific & Medical Officer at Vidus Ocular. There is no recent news or activity for this profile.See details»